Elisrasib elicits promising response rates in patients with advanced lung cancer
Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors
Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors
Discover how Quadram Institute researcher Dr Amisha Modasia is bridging the gap between dietary fiber and whole body wellness to celebrate Medical Laboratory Professionals Week 2026
An updated trial analysis presented at AACR 2026 showed that the investigational KRAS G12D inhibitor zoldonrasib demonstrated clinical activity with a favorable safety profile in previously treated KRAS G12D‑mutant NSCLC patients
In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes
Extended immunotherapy showed manageable long‑term safety in adolescents and young adults with alveolar soft part sarcoma, according to phase II data presented at AACR 2026
The AACR will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026
Cast your vote in the 2026 Scientists' Choice Awards for the product that has made the most difference to your lab
At-home self-collection reduces significant barriers for unscreened or under-screened individuals
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments
Why software integration is the key to reproducible, data-driven biologics workflows
The bottlenecks of manual ELISA are well known, but modern liquid handling tools offer a practical way to fix them
Minimally invasive blood test enables greater patient access to monitoring of neuroinflammatory status versus current standard of care methods
BIOFIRE SPOTFIRE introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients
Povair Sciences addresses critical bottlenecks in mAb development with innovative filtration solutions
Up to 100 percent transfer efficiency and viability to protect top clones for downstream expansion
Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor Controllers, as well as BIOne Single-Use Bioreactors and Fermentors
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
Signals BioDesign is a cloud-native molecular cloning solution that enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing
SPINRAZA is an antisense oligonucleotide therapy that increases production of survival motor neuron (SMN) protein, essential for motor neuron function
Discover how free software can help design oligos for PCR assays, reducing guesswork and enabling creation of effective diagnostic assays
The S series with full stainless-steel body is specially designed for GMP/GLP labs
The technology selectively shuts down cancer reproducing cells
Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development
Strategic collaboration integrates organ-on-chip technology into preclinical glioblastoma research to improve translational relevance